Ana María Vesga
Ana María Vesga is the President of the Colombian Association of Integrated Medicine Companies (Acemi). In recent news, she emphasized the financial difficulties faced by health promoting companies (EPS) in Colombia, particularly those intervened in 2024, which may be at risk of liquidation due to significant losses and inadequate solutions for the healthcare system.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Colombia | 2 | 5.50 | 0.16% | +0% | 50,882,884 | 82,669 | $350,000 | 569$ |
| Totals | 2 | 50,882,884 | 82,669 | $350,000 | 569$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Colombia:
Ana María Vesga is the president of Acemi.
5
Colombia:
Ana María Vesga, the executive president of Acemi, highlighted the negative impact of Nueva EPS's financial situation on its 11 million affiliates.
6
Colombia:
Ana María Vesga criticized the decree as untimely and imprudent.
4
Colombia:
Ana María Vesga, president of Acemi, warned that the decree introduces substantial changes to how EPS will operate in the territory.
6
Colombia:
Ana María Vesga, presidenta ejecutiva de Acemi, advirtió sobre el alto riesgo de que los traslados se traduzcan en deterioro de la atención.
6
Colombia:
Ana María Vesga, presidenta ejecutiva de Acemi, ha advertido los riesgos de esta medida.
6
Colombia:
Ana María Vesga, presidenta de Acemi, advirtió que 'existe un alto riesgo de que esos traslados se traduzcan en deterioro de la atención'.
5
Colombia:
Ana María Vesga, president of Acemi, acknowledges the fundamental principle of prevention in health systems but points out deep flaws in the government's approach to primary care.
4
Colombia:
Ana María Vesga, president of Acemi, stated that the failure of the health reform was due to a lack of dialogue.
5
Colombia:
Ana María Vesga is the president of Acemi who warns about the structural changes in the health model.
3